Reporting and Contact Us
REPORTING A SAFETY CONCERN
Kyowa Kirin takes patient safety seriously. We routinely monitor information from multiple sources regarding the safety of our products in order to take any necessary actions. If you would like to report a possible side effect of a Kyowa Kirin product, please provide any relevant information you have about the side effect and if possible please include the following information:
1. The initials of the person who experienced the possible side effect and/or other identifiers, such as gender or date of birth
2. The contact information of the person reporting the issue
3. A description of the side effect, such as the signs and symptoms experienced, date the side effect started, and the outcome of the side effect
4. The name of the Kyowa Kirin product and date the person who experienced the side effect began taking it
Please select your country to contact us and/or report a safety concern
Austria
We are committed to an environment where open, honest communications are the expectation, not the exception. We encourage all who work or engage with us to report any matters of concern freely and openly at the earliest possible opportunity.
To do so, we encourage you to use this Speak Up Line hosted by a third party provider, EthicsPoint. https://secure.ethicspoint.eu/domain/media/en/gui/105727/index.html
Bahrain
For reporting any side effects or safety information, please contact us directly via:
E-mail: drugsafetygcc@kyowakirin.com
Hotline: +971 55 187 4456 | Landline: +971 4 581 3700 | Fax: +971 4 581 3776
Please contact the relevant competent authority.
Belgium
We are committed to an environment where open, honest communications are the expectation, not the exception. We encourage all who work or engage with us to report any matters of concern freely and openly at the earliest possible opportunity.
To do so, we encourage you to use this Speak Up Line hosted by a third party provider, EthicsPoint. https://secure.ethicspoint.eu/domain/media/en/gui/105727/index.html
Czech Republic
To do so, we encourage you to use this Speak Up Line hosted by a third party provider, EthicsPoint. https://secure.ethicspoint.eu/domain/media/en/gui/105727/index.html
France
La déclaration des effets indésirables suspectés après autorisation du médicament est importante. Elle permet une surveillance continue du rapport bénéfice/risque du médicament. En signalant les effets indésirables, vous contribuez à améliorer la connaissance sur le profil de tolérance des produits.
Déclarez immédiatement tout effet indésirable suspecté d’être dû à un médicament à votre Centre régional de pharmacovigilance (CRPV) ou sur https://signalement.social-sante.gouv.fr
Germany
MELDUNG EINES SICHERHEITSANLIEGENS
Für Kyowa Kirin steht das Thema „Patientensicherheit“ an erster Stelle. Wir überwachen routinemäßig Informationen aus verschiedenen Quellen bezüglich der Sicherheit unserer Produkte, um gegebenenfalls erforderliche Maßnahmen zu ergreifen.
Wenn Sie eine potenzielle Nebenwirkung eines Kyowa Kirin-Produkts melden möchten, geben Sie bitte alle relevanten Informationen an, zu denen insbesondere die folgenden Informationen zählen:
- Die Initialen der Person, bei der die mögliche Nebenwirkung aufgetreten ist, und/oder andere Identifikatoren, wie Geschlecht oder Geburtsdatum
- Die Kontaktinformationen der Person, die das Problem gemeldet hat
- Eine Beschreibung der Nebenwirkung, wie etwa die aufgetretenen Symptome, das Datum, an dem die Nebenwirkung auftrat, sowie das Ergebnis der Nebenwirkung
- Der Name des Kyowa Kirin-Produkts und das Datum, an dem die Person, bei der die Nebenwirkung auftrat, mit der Einnahme begann
Ireland
For Ireland, reporting forms and further information can be found at www.hpra.ie . By reporting side effects, you can help provide more information on the safety of medicines. Adverse events should also be reported using the contact form below.
We are committed to an environment where open, honest communications are the expectation, not the exception. We encourage all who work or engage with us to report any matters of concern freely and openly at the earliest possible opportunity.
To do so, we encourage you to use this Speak Up Line hosted by a third party provider, EthicsPoint. https://secure.ethicspoint.eu/domain/media/en/gui/105727/index.html
Italy
SEGNALARE UN PROBLEMA DI SICUREZZA
Kyowa Kirin prende sul serio la sicurezza dei pazienti. Monitoriamo regolarmente le informazioni provenienti da più fonti inerenti alla sicurezza dei nostri prodotti al fine di intraprendere le azioni necessarie. Se desiderate segnalare un possibile effetto collaterale di un prodotto Kyowa Kirin, occorrerà fornire tutte le informazioni pertinenti di cui si dispone circa l’effetto collaterale e, se possibile, includere le seguenti informazioni:
- Le iniziali della persona che ha riscontrato il possibile effetto collaterale e/o altri identificatori, quali sesso o data di nascita
- Le informazioni di contatto della persona che segnala il problema
- Una descrizione dell'effetto collaterale, ad esempio i segni e i sintomi riscontrati, la data di inizio dell'effetto collaterale e l'esito dell'effetto collaterale
- Il nome del prodotto Kyowa Kirin e la data in cui la persona che ha riscontrato l'effetto collaterale ha iniziato ad assumerlo
We are committed to an environment where open, honest communications are the expectation, not the exception. We encourage all who work or engage with us to report any matters of concern freely and openly at the earliest possible opportunity.
To do so, we encourage you to use this Speak Up Line hosted by a third party provider, EthicsPoint. https://secure.ethicspoint.eu/domain/media/en/gui/105727/index.html
Kuwait
For reporting any side effects or safety information, please contact us directly via:
E-mail: drugsafetygcc@kyowakirin.com
Hotline: +971 55 187 4456 | Landline: +971 4 581 3700 | Fax: +971 4 581 3776
Please contact the relevant competent authority.
Luxembourg
We are committed to an environment where open, honest communications are the expectation, not the exception. We encourage all who work or engage with us to report any matters of concern freely and openly at the earliest possible opportunity.
To do so, we encourage you to use this Speak Up Line hosted by a third party provider, EthicsPoint. https://secure.ethicspoint.eu/domain/media/en/gui/105727/index.html
Nederland
Wij streven naar een omgeving waarin open en eerlijke communicatie de verwachting is, niet de uitzondering. We moedigen iedereen aan die met ons samenwerkt of met ons zaken doet om eventuele zorgen zo snel mogelijk vrij en openlijk te melden. Hiervoor raden we u aan gebruik te maken van de Speak Up Line van een externe provider: EthicsPoint.
https://secure.ethicspoint.eu/domain/media/da/gui/105727/index.html
Nordics and Baltics
We are committed to an environment where open, honest communications are the expectation, not the exception. We encourage all who work or engage with us to report any matters of concern freely and openly at the earliest possible opportunity.
To do so, we encourage you to use this Speak Up Line hosted by a third party provider, EthicsPoint. https://secure.ethicspoint.eu/domain/media/en/gui/105727/index.html
Oman
For reporting any side effects or safety information, please contact us directly via:
E-mail: drugsafetygcc@kyowakirin.com
Hotline: +971 55 187 4456 | Landline: +971 4 581 3700 | Fax: +971 4 581 3776
Please contact the relevant competent authority.
Portugal
We are committed to an environment where open, honest communications are the expectation, not the exception. We encourage all who work or engage with us to report any matters of concern freely and openly at the earliest possible opportunity.
To do so, we encourage you to use this Speak Up Line hosted by a third party provider, EthicsPoint. https://secure.ethicspoint.eu/domain/media/en/gui/105727/index.html
Qatar
For reporting any side effects or safety information, please contact us directly via:
E-mail: drugsafetygcc@kyowakirin.com
Hotline: +971 55 187 4456 | Landline: +971 4 581 3700 | Fax: +971 4 581 3776
Please contact the relevant competent authority.
Saudi Arabia
For reporting any side effects or safety information, please contact us directly via:
E-mail: drugsafetygcc@kyowakirin.com
Hotline: +971 55 187 4456 | Landline: +971 4 581 3700 | Fax: +971 4 581 3776
Saudi Arabia: - The National Pharmacovigilance and Drug Safety Centre (NPC):
Fax: +966-11-205-7662 | SFDA Call Center: 19999
E-mail: npc.drug@sfda.gov.sa
Website: https://ade.sfda.gov.sa/
Spain
Estamos comprometidos con un entorno en el que la comunicación abierta y honesta sea la expectativa, no la excepción. Animamos a todos los que trabajan o se relacionan con nosotros a que nos informen libre y abiertamente de cualquier asunto que les preocupe lo antes posible.
Para ello, le animamos a que utilice la línea de denuncia de EthicsPoint, un proveedor externo.
https://secure.ethicspoint.eu/domain/media/en/gui/105727/index.html
Switzerland
We are committed to an environment where open, honest communications are the expectation, not the exception. We encourage all who work or engage with us to report any matters of concern freely and openly at the earliest possible opportunity.
To do so, we encourage you to use this Speak Up Line hosted by a third party provider, EthicsPoint. https://secure.ethicspoint.eu/domain/media/en/gui/105727/index.html
Orders
For orders in the Swiss market, click here.
United Arab Emirates
For reporting any side effects or safety information, please contact us directly via:
E-mail: drugsafetygcc@kyowakirin.com
Hotline: +971 55 187 4456 | Landline: +971 4 581 3700 | Fax: +971 4 581 3776
Please contact the relevant competent authority.
United Kingdom
UK Reporting and Contact form
Adverse events should be reported. Reporting forms and information can be found at https://yellowcard.mhra.gov.uk/ or search MHRA Yellow Card in the Google Play or Apple App store. Adverse events should also be reported using the contact form below.
Adverse events should also be reported to
Kyowa Kirin on +44 (0)1896 664 000
We are committed to an environment where open, honest communications are the expectation, not the exception. We encourage all who work or engage with us to report any matters of concern freely and openly at the earliest possible opportunity.
To do so, we encourage you to use this Speak Up Line hosted by a third party provider, EthicsPoint. https://secure.ethicspoint.eu/domain/media/en/gui/105727/index.html
Copyright © Kyowa Kirin International plc. All rights reserved. This website is developed and funded by Kyowa Kirin International plc.
Kyowa Kirin International plc is a company registered in Scotland (company number SC198780) with registered address at Galabank Business Park, Galashiels TD1 1QH, United Kingdom.
KKI/INT/KKI/0913 September 2024